Nymox Pharmaceutical
NYMX
#10153
Rank
C$25.07 M
Marketcap
Country
C$0.27
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Categories
EPS for Nymox Pharmaceutical (NYMX)
EPS in 2023 (TTM): C-$0.08142
According to Nymox Pharmaceutical's latest financial reports the company's current EPS (TTM) is C-$0.08242. In 2022 the company made an earnings per share (EPS) of C-$0.11 an increase over its 2021 EPS that were of C-$0.21.
EPS history for Nymox Pharmaceutical from 1997 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | C-$0.08142 | -25.91% |
| 2022 | C-$0.11 | -46.67% |
| 2021 | C-$0.21 | -11.76% |
| 2020 | C-$0.23 | -15% |
| 2019 | C-$0.27 | 5.26% |
| 2018 | C-$0.26 | -26.92% |
| 2017 | C-$0.36 | -7.14% |
| 2016 | C-$0.38 | -40.43% |
| 2015 | C-$0.65 | 291.67% |
| 2014 | C-$0.16 | -7.69% |
| 2013 | C-$0.18 | -43.48% |
| 2012 | C-$0.32 | -25.81% |
| 2011 | C-$0.43 | 55% |
| 2010 | C-$0.27 | 25% |
| 2009 | C-$0.22 | 0.08% |
| 2008 | C-$0.22 | -11.12% |
| 2007 | C-$0.25 | -0.16% |
| 2006 | C-$0.25 | 28.59% |
| 2005 | C-$0.19 | -12.49% |
| 2004 | C-$0.22 | -16.05% |
| 2003 | C-$0.26 | 19.07% |
| 2002 | C-$0.22 | 14.45% |
| 2001 | C-$0.19 | -22.16% |
| 2000 | C-$0.25 | 5.64% |
| 1999 | C-$0.23 | -34.59% |
| 1998 | C-$0.36 | -3.6% |
| 1997 | C-$0.37 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Abbott Laboratories ABT | C$10.70 | -13,077.95% | 🇺🇸 USA |
 Pfizer PFE | C$1.91 | -2,416.67% | 🇺🇸 USA |
 Quest Diagnostics
DGX | C$11.00 | -13,450.00% | 🇺🇸 USA |
 Eli Lilly LLY | C$16.97 | -20,693.33% | 🇺🇸 USA |
 Johnson & Johnson JNJ | C$12.46 | -15,212.78% | 🇺🇸 USA |